Clínic Barcelona

IDIBAPS establishes a new research group devoted to cellular immunotherapies aimed at combatting cancer

The IDIBAPS Board of Governors has approved the creation of a new research group. The decision follows the scientific evaluation of the researchers – who are engaged in the Ramón y Cajal programme – carried out by the ad hoc committee and the external scientific council, in accordance with the IDIBAPS research career strategy document.

The IDIBAPS researcher Sònia Guedan.

Keep reading about:

Related news